Filter
964
Filtered Results: 964
Text search:
Global
Burden
of
Disease
Health
Financing
Collaborator
Network
Featured
Recommendations
68
New Publications
293
Language
Document type
No document type
585
Studies & Reports
187
Strategic & Response Plan
78
Guidelines
66
Manuals
33
Training Material
4
Situation Updates
4
Fact sheets
4
Resource Platforms
2
Brochures
1
Countries / Regions
Global
59
Kenya
44
Western and Central Europe
43
Nigeria
26
Ethiopia
23
Uganda
21
Latin America and the Carribbean
21
Africa
21
Myanmar / Burma
20
Eastern Europe
20
Sierra Leone
19
Liberia
19
Rwanda
19
Zambia
17
Ghana
16
India
15
Bangladesh
15
Malawi
15
South–East Asia Region
13
Nepal
12
Tanzania
12
Cambodia
12
Ukraine
12
Namibia
11
Philippines
10
South Africa
10
Lesotho
10
Asia
9
Botswana
8
South Sudan
6
East and Southern Africa
6
Eastern Europe and Central Asia
6
Senegal
5
Congo, Democratic Republic of
5
Pakistan
5
West and Central Africa
5
Western Pacific Region
5
Zimbabwe
4
Syria
4
Mozambique
4
Eswatini/ Swaziland
4
Cameroon
3
Indonesia
3
Sudan
3
North Macedonia
3
Moldova
3
Georgia
3
Guinea
2
Burkina Faso
2
Haiti
2
Somalia
2
Afghanistan
2
Thailand
2
Middle East and North Africa
2
Albania
2
Laos
2
Tajikistan
2
Russia
2
Vietnam
2
North America
2
Jordan
1
Germany
1
Gambia
1
Papua New Guinea
1
Central African Republic
1
Peru
1
Hungary
1
Ecuador
1
Chile
1
Other region
1
Poland
1
Southern Africa
1
Qatar
1
Bulgaria
1
Romania
1
Slovakia
1
Kyrgyzstan
1
Japan
1
Authors & Publishers
Publication Years
Category
Countries
412
Public Health
84
Clinical Guidelines
54
Key Resources
41
Women & Child Health
34
Capacity Building
6
Pharmacy & Technologies
4
Toolboxes
TB
103
HIV
85
COVID-19
59
Planetary Health
42
Mental Health
38
Global Health Education
32
AMR
32
Health Financing Toolbox
29
Disability
22
Rapid Response
21
Conflict
19
NCDs
19
Caregiver
17
NTDs
13
Polio
9
Ebola
7
Refugee
6
Pharmacy
6
Natural Hazards
5
Cholera
3
Social Ethics
2
Zika
1
Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an ...
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report ...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a c...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of...
The Global Burden of Disease (GBD) study, a collaborative endeavour ... the World
Health Organization (WHO), the World Bank and the Harvard School of Public Health,
drew the attention of the international health community to the burden of neurological
disorders and many other chronic conditions. This study found that the burden of neurological
disorders was seriously underestimated by traditional epidemiological and health
statistical methods that take into account only mortality rates but not disability rates. The
GBD study showed that over the years the global health impact of neurological disorders
had been underestimated.
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD ... and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epidemiological transition on the continent, where NCDs is projected
to outpace communicable diseases within the current decade. Unchecked
increases in CVD risk factors have contributed to the growing burden of three
major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age
standardized disability-adjusted life years (DALYs) due to hypertensive heart
disease (HHD) were recorded in Africa. The contributory causes of heart failure
are changing—whilst HHD and cardiomyopathies still dominate, ischemic
heart disease is rapidly becoming a significant contributor, whilst rheumatic
heart disease (RHD) has shown a gradual decline. In a continent where health
systems are traditionally geared toward addressing communicable diseases,
several gaps exist to adequately meet the growing demand imposed by CVDs.
Among these, high-quality research to inform interventions, underfunded
health systems with high out-of-pocket costs, limited accessibility and
affordability of essential medicines, CVD preventive services, and skill
shortages. Overall, the African continent progress toward a third reduction
in premature mortality come 2030 is lagging behind. More can be done in
the arena of effective policy implementation for risk factor reduction and
CVD prevention, increasing health financing and focusing on strengthening
primary health care services for prevention and treatment of CVDs, whilst
ensuring availability and affordability of quality medicines. Further, investing
in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on
interventions. This review summarizes the current CVD burden, important
gaps in cardiovascular medicine in Africa, and further highlights priority
areas where efforts could be intensified in the next decade with potential
to improve the current rate of progress toward achieving a 33% reduction
in CVD mortality.
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical ... (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-ended list of some 20 parasitic, bacterial, viral, protozoan and helminthic infections. Called “diseases of the poor,” because of their characteristic prevalence in poor populations regardless of a country's income status, they infect over one billion people in over 140 countries, with about 90% of the global burden in Africa. While NTDs do not contribute significantly to global deaths, they are debilitating and remain the most common infections among the poor worldwide, preventing them from escaping poverty by impacting livelihoods such as agriculture and livestock, and affecting cognitive, developmental and education outcomes.
The 2020 Report analyzes global health spending for 190 countries from 2000 to 2018 and provides insights as to the health spending trajectory from...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR ... Action Plan and the African Union Framework for Antimicrobial Resistance Control 2020 – 2025, which is tailored to meet the specific needs of African nations through a coordinated approach. While most countries in the region have developed and prioritized National Action Plans (NAPs) to tackle AMR, the overall response remains inadequate given the magnitude of the threat, which endangers human, animal, environmental, aquatic, and plant health.
Africa bears a significant burden of infectious diseases, accounting for approximately 95% of malaria deaths, 70% of people living with HIV, and 25% of TB deaths globally. In 2019, AMR was linked to approximately 55,000 deaths from HIV, 30,000 from malaria, and 255,000 overall. Major drivers of AMR in the region include the overuse and misuse of antimicrobials in human and food systems, migration, suboptimal vaccination rates, and environmental contamination from hospital and pharmaceutical effluents. Additionally, there is a lack of access to quality-assured antimicrobials and diagnostics, compounded by inadequate knowledge about AMR. Unlike high-income countries, where indiscriminate antimicrobial use is the primary factor driving AMR, African countries face additional challenges, including a lack of access to clean and safe water, poor Water, Sanitation, and Hygiene (WASH) programs, inadequate infection prevention measures, and suboptimal vaccinations for preventable diseases. One in three hospitals in the region lacks clean, safe running water, and one in eight people defecate openly due to inadequate sanitation. Investments in WASH, infection prevention, and biosecurity could save approximately 700,000 lives annually.
Addressing AMR in Africa requires a comprehensive, multi-sectoral approach involving the entire society. Sustainable access to antimicrobials, including antibiotics, vaccines, and therapeutics, is crucial, as lack of access leads to more morbidity and mortality than AMR itself. Support for the region should focus on preventing infections, strengthening health and food systems, developing human resources, ensuring sustainable access to diagnostics and therapeutics, and investing in laboratory infrastructure to support surveillance and data generation.
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory ...
Financing Global Health 2016: Development Assistance, Public and Private Health Spending for the...
The Sustainable Development Goals (SDGs) call for major societal transformations that will require significant fiscal outlays as well as private investments. The fiscal outlays cover public investments, the public provision of social services, and s...
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global...
Stronger collaboration, better health: global action plan for healthy lives and well-being for all
recommended
The overall objective of the Global Action Plan is to enhance collaboration among 12 global orga...
In 2017, $37.4 billion of development assistance was provided to low- and middleincome countries to maintain or improve health. This amount is down slightly compared to 2016, and since 2010, develop...
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing ... health and development landscape, considering the implications of integrating these diseases into the broader 2030 Agenda for Sustainable Development.
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory ...
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network
The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw.
...
Regional Network for Equity in Health in east and southern Africa (EQUINET): Disussion Paper 111
The health services delivery system in Zambia...
The health services delivery system in Zambia...
Water, sanitation and hygiene (WASH) are critical in the prevention and care for all of the 17 neglected tropical diseases (NTDs) scheduled for intensified control or elimination by 2020.
Provi...
Provi...
